Pfizer's Melanoma Failure Will Hit Others
Fallout from the halt of a phase III study will extend beyond Pfizer, which saw shares drop 1% after hours. 7 months ago
TheStreet Click here to Read the Full StoryFallout from the halt of a phase III study will extend beyond Pfizer, which saw shares drop 1% after hours. 7 months ago
TheStreet Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook